S.c.a. Candriam

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Investment type: Debt / NOTE 0.599% 8/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Jun 2024		-0%	$0	0	-250	-100%		Q2 2024
31 Mar 2024	0%	0%	$246	250	0		98.4%	Q1 2024
31 Dec 2023	0%	-0%	$247	250	-600	-71%	98.8%	Q4 2023
30 Sep 2023	0%	0%	$826	850	0		97.18%	Q3 2023
30 Jun 2023	0%	+0%	$838	850	+600	+240%	98.59%	Q2 2023
31 Mar 2023	0%	0%	$236	250	0		94.4%	Q1 2023
31 Dec 2022	0%	-0%	$266	250	-200	-44%	106.4%	Q4 2022
30 Sep 2022	0%	-0%	$448	450	-350	-44%	99.56%	Q3 2022
30 Jun 2022	0%	0%	$794	800	0		99.25%	Q2 2022
31 Mar 2022	0%	0%	$806	800	0		100.75%	Q1 2022
31 Dec 2021	0%	0%	$842	800	0		105.25%	Q4 2021
30 Sep 2021	0%	0%	$822	800	0		102.75%	Q3 2021
30 Jun 2021	0.01%	0%	$835,000	800	0		104375.0%	Q2 2021
31 Mar 2021	0.01%	0%	$830,000	800	0		103750.0%	Q1 2021
31 Dec 2020	0.01%	+0.01%	$864,000	800	+800	NEW	108000.0%	Q4 2020
30 Sep 2020		-0.03%	$0	0	-2,600	-100%		Q3 2020
30 Jun 2020	0.03%	-0.01%	$3,198,000	2,600	-400	-13%	123000.0%	Q2 2020
31 Mar 2020	0%	0%	$3,117	3,000	0		103.9%	Q1 2020
31 Dec 2019	0%	0%	$3,188	3,000	0		106.27%	Q4 2019
30 Sep 2019	0%	0%	$2,959	3,000	0		98.63%	Q3 2019
30 Jun 2019	0%	+0%	$3,113	3,000	+3,000	NEW	103.77%	Q2 2019
31 Dec 2018		-0%	$0	0	-200	-100%		Q4 2018
30 Sep 2018	0%	0%	$213	200	0		106.5%	Q3 2018
30 Jun 2018	0%	-0%	$204	200	-200	-50%	102.0%	Q2 2018
31 Mar 2018	0%	+0%	$378	400	+100	+33%	94.5%	Q1 2018
31 Dec 2017	0%	+0%	$300	300	+100	+50%	100.0%	Q4 2017
30 Sep 2017	0%	+0%	$203,000	200	+200	NEW	101500.0%	Q3 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.